Grand Cayman, Cayman Islands In 2004 was created Maison Capital, which is appeared as VC. The main office of represented VC is situated in the Grand Cayman. The fund was located in North America if to be more exact in Cayman Islands.
For fund there is no match between the location of its establishment and the land of its numerous investments - China. We can highlight the next thriving fund investment areas, such as Food Delivery, 3D Technology. Among the most popular portfolio startups of the fund, we may highlight NASN Automotive Electronics, iXiandou, SinoUnited Health Clinic. Moreover, a startup needs to be at the age of 2-3 years to get the investment from the fund. The fund has no exact preference in a number of founders of portfolio startups. When startup sums 4 or 5+ of the founder, the probability for it to get the investment is little.
The important activity for fund was in 2019. Considering the real fund results, this VC is 34 percentage points more often commits exit comparing to other organizations. Deals in the range of 10 - 50 millions dollars are the general things for fund. The fund is constantly included in 2-6 deals per year.
Besides them, we counted 8 critical employees of this fund in our database.
The usual cause for the fund is to invest in rounds with 2-3 partakers. Despite the Maison Capital, startups are often financed by ZhenFund, Qiming Venture Partners, Matrix Partners China. The meaningful sponsors for the fund in investment in the same round are Qiming Venture Partners, Seas Capital, Matrix Partners China. In the next rounds fund is usually obtained by Qiming Venture Partners, Yunyi Capital, U.S.-China Green Fund.
Related Funds
Discover 5 more decision makers Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
Enxi Village | 21 Apr 2022 | Shenzhen, Guangdong, China | |||
AUTHINE | $15M | 01 Mar 2022 | Futian District, Guangdong Province, China | ||
Zhongke Digital | 21 Dec 2021 | Haidian District, Beijing, China | |||
Zbeetle | $15M | 19 Nov 2021 | Shenzhen, Guangdong, China | ||
Insilico Medicine | $255M | 22 Jun 2021 | Hong Kong Island, Hong Kong, China | ||
Yongpu Kafei | $7M | 10 Jun 2021 | Shanghai, Shanghai, China | ||
| $105M | 13 May 2021 | Shanghai, China | |||
Xuan's Mom | $16M | 27 Apr 2021 | Jiangmen, Guangdong Province, China | ||
Simple Love | $123M | 25 Mar 2021 | Yuexiu District, Guangdong Province, China |
– Insilico Medicine announced that it has closed a $255m Series C.
– The financing led by Warburg Pincus, and participated by current investors including Qiming Venture Partners, Pavilion Capital, Eight Roads Ventures, Lilly Asia Ventures, Sinovation Ventures, BOLD Capital Partners, Formic Ventures, Baidu Ventures, and new investors including CPE, OrbiMed, Mirae Asset Capital, B Capital Group, Deerfield Management, Maison Capital, Lake Bleu Capital, President International Development Corporation, Sequoia Capital China and Sage Partners.
– The financing will be used to progress Insilico Medicine’s current therapeutic programs into human clinical trials, initiate multiple new programs for novel and difficult targets, and further develop its AI and drug discovery capabilities.
– HiFiBiO Therapeutics, a biotechnology company with expertise in immune modulation and drug intelligent science, announced the completion of an oversubscribed $75M Series D financing round.
– The funding was led by the new investor Mirae Asset Financial Group.
– B Capital Group, Sherpa, Maison Capital, Trinity Innovation Fund, Grand Mount, and HKSTP Venture Fund also participated in this round.
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
Enxi Village | 21 Apr 2022 | Shenzhen, Guangdong, China | |||
AUTHINE | $15M | 01 Mar 2022 | Futian District, Guangdong Province, China | ||
Zhongke Digital | 21 Dec 2021 | Haidian District, Beijing, China | |||
Zbeetle | $15M | 19 Nov 2021 | Shenzhen, Guangdong, China | ||
Insilico Medicine | $255M | 22 Jun 2021 | Hong Kong Island, Hong Kong, China | ||
Yongpu Kafei | $7M | 10 Jun 2021 | Shanghai, Shanghai, China | ||
| $105M | 13 May 2021 | Shanghai, China | |||
Xuan's Mom | $16M | 27 Apr 2021 | Jiangmen, Guangdong Province, China | ||
Simple Love | $123M | 25 Mar 2021 | Yuexiu District, Guangdong Province, China |
